» Articles » PMID: 28483418

Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2017 May 10
PMID 28483418
Citations 205
Authors
Affiliations
Soon will be listed here.
Abstract

Monomethylation of histone H3 at lysine 4 (H3K4me1) and acetylation of histone H3 at lysine 27 (H3K27ac) are correlated with transcriptionally engaged enhancer elements, but the functional impact of these modifications on enhancer activity is not well understood. Here we used CRISPR/Cas9 genome editing to separate catalytic activity-dependent and independent functions of Mll3 (Kmt2c) and Mll4 (Kmt2d, Mll2), the major enhancer H3K4 monomethyltransferases. Loss of H3K4me1 from enhancers in Mll3/4 catalytically deficient cells causes partial reduction of H3K27ac, but has surprisingly minor effects on transcription from either enhancers or promoters. In contrast, loss of Mll3/4 proteins leads to strong depletion of enhancer Pol II occupancy and eRNA synthesis, concomitant with downregulation of target genes. Interestingly, downregulated genes exhibit reduced polymerase levels in gene bodies, but not at promoters, suggestive of pause-release defects. Altogether, our results suggest that enhancer H3K4me1 provides only a minor contribution to the long-range coactivator function of Mll3/4.

Citing Articles

Application Strategies of Super-Enhancer RNA in Cardiovascular Diseases.

He Y, Cai Y, Cao Y, Wang Y, Wang J, Ding H Biomedicines. 2025; 13(1).

PMID: 39857701 PMC: 11762524. DOI: 10.3390/biomedicines13010117.


Loss of Kmt2c or Kmt2d primes urothelium for tumorigenesis and redistributes KMT2A-menin to bivalent promoters.

Wang N, Pachai M, Li D, Lee C, Warda S, Khudoynazarova M Nat Genet. 2025; 57(1):165-179.

PMID: 39806204 PMC: 11735410. DOI: 10.1038/s41588-024-02015-y.


Super-enhancers in hepatocellular carcinoma: regulatory mechanism and therapeutic targets.

Lu X, Zhu M, Pei X, Ma J, Wang R, Wang Y Cancer Cell Int. 2025; 25(1):7.

PMID: 39773719 PMC: 11706108. DOI: 10.1186/s12935-024-03599-5.


Long-range regulation of transcription scales with genomic distance in a gene-specific manner.

Jensen C, Chen L, Swigut T, Crocker O, Yao D, Bassik M Mol Cell. 2024; 85(2):347-361.e7.

PMID: 39626660 PMC: 11741922. DOI: 10.1016/j.molcel.2024.10.021.


Evidence for dual roles of histone H3 lysine 4 in antagonizing Polycomb group function and promoting target gene expression.

Anyetei-Anum C, Leatham-Jensen M, Fox G, Smith B, Chirasani V, Krajewski K Genes Dev. 2024; 38(21-24):1033-1046.

PMID: 39562140 PMC: 11610931. DOI: 10.1101/gad.352181.124.


References
1.
Yuan Z, Lin S, Molden R, Cao X, Bhanu N, Wang X . EpiProfile Quantifies Histone Peptides With Modifications by Extracting Retention Time and Intensity in High-resolution Mass Spectra. Mol Cell Proteomics. 2015; 14(6):1696-707. PMC: 4458730. DOI: 10.1074/mcp.M114.046011. View

2.
Sidoli S, Bhanu N, Karch K, Wang X, Garcia B . Complete Workflow for Analysis of Histone Post-translational Modifications Using Bottom-up Mass Spectrometry: From Histone Extraction to Data Analysis. J Vis Exp. 2016; (111). PMC: 4927705. DOI: 10.3791/54112. View

3.
Bonn S, Zinzen R, Girardot C, Gustafson E, Perez-Gonzalez A, Delhomme N . Tissue-specific analysis of chromatin state identifies temporal signatures of enhancer activity during embryonic development. Nat Genet. 2012; 44(2):148-56. DOI: 10.1038/ng.1064. View

4.
Karlic R, Chung H, Lasserre J, Vlahovicek K, Vingron M . Histone modification levels are predictive for gene expression. Proc Natl Acad Sci U S A. 2010; 107(7):2926-31. PMC: 2814872. DOI: 10.1073/pnas.0909344107. View

5.
Herz H, Mohan M, Garruss A, Liang K, Takahashi Y, Mickey K . Enhancer-associated H3K4 monomethylation by Trithorax-related, the Drosophila homolog of mammalian Mll3/Mll4. Genes Dev. 2012; 26(23):2604-20. PMC: 3521626. DOI: 10.1101/gad.201327.112. View